Symptomatic DVT · women at increased risk of VTE in the early postpartum period
1 finding from 1 review
Symptomatic PE · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
It is very uncertain whether antenatal (± postnatal) prophylaxis: heparin (LMWH or UFH) changes symptomatic PE ( compared with no treatment/placebo (very low certainty).
1 finding from 1 review
Adverse effects sufficient to stop treatment · women at increased risk of VTE in the early postpartum period
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic DVT · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
It is very uncertain whether antenatal (± postnatal) prophylaxis: heparin (LMWH or UFH) changes symptomatic DVT ( compared with no treatment/placebo (very low certainty).
1 finding from 1 review
Adverse effects sufficient to stop treatment · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
It is very uncertain whether antenatal (± postnatal) prophylaxis: heparin (LMWH or UFH) changes adverse effects sufficient to stop treatment compared with no treatment/placebo (very low certainty).
1 finding from 1 review
Maternal death · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic thromboembolic events ( · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
It is very uncertain whether antenatal (± postnatal) prophylaxis: LMWH changes symptomatic thromboembolic events ( compared with UFH (very low certainty).
1 finding from 1 review
Symptomatic PE · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
1 finding from 1 review
Symptomatic DVT · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
1 finding from 1 review
Maternal death · mothers and infants receiving home visits in the early postpartum period
It is very uncertain whether schedules involving more changes maternal mortality within 42 days post‐birth compared with fewer home visits (very low certainty).
1 finding from 1 review
Neonatal mortality · mothers and infants receiving home visits in the early postpartum period
It is very uncertain whether schedules involving more changes neonatal mortality compared with fewer home visits (very low certainty).
1 finding from 1 review
Postnatal depression · mothers and infants receiving home visits in the early postpartum period
1 finding from 1 review
Maternal satisfaction with postnatal care · mothers and infants receiving home visits in the early postpartum period
Schedules involving more showed no clear difference in maternal satisfaction with postnatal care compared with fewer home visits (low certainty).
1 finding from 1 review
Serious neonatal morbidity · mothers and infants receiving home visits in the early postpartum period
1 finding from 1 review
Exclusive breastfeeding at 4‐6 weeks · mothers and infants receiving home visits in the early postpartum period
Schedules involving more may leads to higher exclusive breastfeeding (last assessment up to 6 weeks) compared with fewer home visits (low certainty).
1 finding from 1 review
Adequate pain relief as reported by women · women with perineal pain in the early postpartum period
NSAID may leads to higher adequate pain relief(4 hours after administration) compared with placebo (low certainty).
2 findings from 1 review
Need for additional analgesia (4 hours after administration) · women with perineal pain in the early postpartum period
It is very uncertain whether NSAID (single administration, any dose) changes need for additional analgesia (4 hours after administration) compared with paracetamol (very low certainty).
1 finding from 1 review
Need for additional analgesia (6 hours after administration) · women with perineal pain in the early postpartum period
NSAID (single administration, any dose) may leads to lower need for additional analgesia (6 hours after administration) compared with paracetamol (low certainty).
1 finding from 1 review
Maternal drug adverse effects number of women experiencing adverse effects · women with perineal pain in the early postpartum period
1 finding from 1 review
Maternal drug adverse effects (6 hours after administration) · women with perineal pain in the early postpartum period
It is very uncertain whether NSAID (single administration, any dose) changes maternal drug adverse effects (6 hours after administration) compared with paracetamol (very low certainty).
1 finding from 1 review